Related Experiment Videos
Bone metastases from bronchial carcinoid tumors. Two case-reports
F Merle-Vincent1, G Chevrel, C Lombard-Bohas
1Rheumatology and Bone Diseases Unit, Edouard Herriot Teaching Hospital, Lyon, France.
Revue Du Rhumatisme (English Ed.)
|February 26, 1999
Summary
Diagnosing metastatic bone disease from bronchial carcinoid tumors is challenging due to slow growth and late primary tumor identification. Case reports highlight varied presentations, including multiple distal bone metastases and elevated serotonin levels.
Area of Science:
- Oncology
- Endocrinology
Background:
- Bronchial carcinoid tumors are rare, slow-growing neuroendocrine malignancies.
- Metastatic bone disease is an uncommon but serious complication.
Observation:
- Two cases of metastatic bone disease secondary to bronchial carcinoid tumors are presented.
- The first case demonstrated a typical presentation with a single bone metastasis.
- The second case exhibited unusual features: numerous bone metastases, distal skeletal involvement, and elevated serum markers.
Findings:
- Bronchial carcinoid tumors can present with diverse patterns of bone metastasis.
- Diagnostic delays are common due to the indolent nature of these tumors.
- Elevated serotonin and 5-hydroxyindoleacetic acid levels may indicate advanced disease.
Implications:
- Increased awareness of varied metastatic patterns is crucial for early diagnosis.
- Metastatic bone disease in bronchial carcinoid tumors requires thorough skeletal evaluation.
- Biochemical markers can aid in identifying advanced or metastatic disease.